US Map / Iowa

State IA

Clinical Trials in Iowa

Recruiting clinical trials with at least one study location in Iowa. Data updated daily from ClinicalTrials.gov.

Total Trials

134

Recruiting Now

134

← Back to US Map

Top Conditions in Iowa

Chronic Lymphocytic Leukemia (4)Non-small Cell Lung Cancer (3)Stage IVB Prostate Cancer AJCC v8 (3)Small Lymphocytic Lymphoma (3)COVID-19 (3)Head and Neck Squamous Cell Carcinoma (2)Oral Cavity Squamous Cell Carcinoma (2)Stage I Lip and Oral Cavity Cancer AJCC v8 (2)Stage II Lip and Oral Cavity Cancer AJCC v8 (2)Multiple Myeloma (2)Crohn's Disease (2)Stage IV Lung Cancer AJCC v8 (2)

Frequently Asked Questions — Clinical Trials in Iowa

How many clinical trials are currently recruiting in Iowa?

ClinicalMetric currently tracks 134 actively recruiting clinical trials with at least one location in Iowa. The total number of registered studies—including active but not currently enrolling trials—is 134. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.

What types of clinical trials are available in Iowa?

Iowa hosts clinical trials across a broad range of medical conditions, including Chronic Lymphocytic Leukemia, Non-small Cell Lung Cancer, Stage IVB Prostate Cancer AJCC v8, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Iowa serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.

How do I join a clinical trial near me in Iowa?

To join a clinical trial in Iowa, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Iowa maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Iowa

NCT05046600 N/A

Registry of Arthrex Hand and Wrist Products

Ulnar/Radial Collateral Ligament Reconstruction

NCT06872892 Phase 3

The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With B...

United States, Argentina, Australia

Boehringer Ingelheim

NCT05890729 Phase 1, Phase 2

A Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis

Pulmonary Sarcoidosis

United States, Czechia, Denmark

NCT06376994 Phase 3

Multi-Center Clean Air Randomized Controlled Trial in COPD

Chronic Obstructive Pulmonary Disease (COPD)

JHSPH Center for Clinical Tria

NCT06822426 Phase 3

Comparing The Safety And Efficacy Of DEFENCATH® In Reducing Central-Line Bloodst...

Central Line Associated Blood Stream Infections (CLABSI)

NCT07073352 N/A

ACEs, SIRT1, and Premature Vascular Aging in Humans

Adverse Childhood Experiences

Nathaniel Jenkins

NCT07073547 Phase 1

A Phase I, Open-label, Multicenter Study to Evaluate the Safety, Tolerability, C...

Multiple Myeloma

NCT07392190 Phase 3

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who ...

United States, Australia, Belgium

Eli Lilly and Company

NCT06172296 Phase 3

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Tre...

Ganglioneuroblastoma, Nodular

United States, Australia, Canada

National Cancer Institute (NCI

NCT06777368 N/A

REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failu...

Aortic Stenosis

Medtronic Cardiovascular

NCT05946213 Phase 3

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in...

Prostate Adenocarcinoma

United States, Canada, Hong Kong

NCT06592924 Phase 3

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Ca...

Prostate Cancer (Adenocarcinoma)

United States, Canada

Canadian Cancer Trials Group

NCT06191640 N/A

Sinus Disease in Young Children With Cystic Fibrosis

Cystic Fibrosis in Children

University of California, Los

NCT06504446 Phase 2

Study to Assess the Efficacy, Safety, and Tolerability of NOC-110 in Adults With...

Refractory or Unexplained Chronic Cough

United States, Belgium, Canada

Nocion Therapeutics

NCT03217110 N/A

Cerebellar Stimulation and Cognitive Control

Krystal Parker, PhD

NCT07006727 Phase 1

Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Soli...

Small Cell Lung Carcinoma

United States, Canada, South Korea

Novartis Pharmaceuticals

NCT06291376 Phase 3

Study of Ravulizumab in Immunoglobulin A Nephropathy (IgAN)

Immunoglobulin A Nephropathy

United States, Argentina, Australia

Alexion Pharmaceuticals, Inc.

NCT05477576 Phase 3

Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated ...

United States, Belgium, Brazil

NCT06586047 EARLY_Phase 1

Breast Cancer PSMA PET

Triple Negative Breast Cancer

Ahmad Shariftabrizi

NCT06958328 Phase 3

Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer

Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma

NCT06604884 N/A

NV PSR INSPIRE-A Pipeline™ Vantage Post Approval Study

Intracranial Aneurysm

Medtronic Neurovascular Clinic

NCT07085104 Phase 1

A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allog...

Systemic Lupus Erythematosus (With and Without Nephritis)

United States, Canada

Allogene Therapeutics

NCT05836987 Phase 3

The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial F...

Atrial Fibrillation

Johns Hopkins University

NCT04852887 Phase 3

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, O...

Stage I Breast Cancer

United States, Canada, Hong Kong

NCT05004493 N/A

Biorepository and Registry for Plasma Exchange Patients

Antibody-mediated Rejection

Charles M Knudson

Page 4 of 6 — 134 trials total

← Prev Next →

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology